CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net loss	$ (26,836)	$ (8,724)
Reconciliation of net loss to net cash (used in) provided by operating activities:
Depreciation of fixed assets and leases	985	876
Provision for bad debt	85	(105)
Provision for write down of inventory	1,394	453
Stock based compensation	491	368
Amortization of debt costs and debt discount	1,704	1,523
Amortization of intangible assets	741	756
Non cash lease expense	103	97
Foreign currency exchange loss	1,597	844
Debt partial extinguishment	0	185
Loss on impairment of intangible assets	8,373	0
Non cash interest expense	1,984	2,020
Change in the fair value of derivative liabilities	1,258	0
Changes in operating assets and liabilities:
Accounts receivable	11,637	892
Inventories	(8,186)	(5,063)
Prepaid expenses, other current receivables and assets	(58)	558
Accounts payable and accrued expenses	1,889	(95)
Operating liabilities	(107)	(85)
Deferred income	0	(551)
Net cash used in operating activities	(2,946)	(6,051)
Cash flows from investing activities:
Capital expenditures	(880)	(2,129)
Net cash used in investing activities	(880)	(2,129)
Cash flows from financing activities:
Proceeds from Revolver	0	5,000
Debt issuance costs	0	(109)
Repurchase of 3.75% senior notes	0	(2,686)
Principal paid on lease obligation	(3)	(3)
Net cash (used in) provided by financing activities	(3)	2,202
Effect of exchange rate on cash and cash equivalents	(651)	(16)
Net decrease in cash, cash equivalents and restricted cash	(4,480)	(5,994)
Cash, cash equivalents and restricted cash at beginning of period	16,182	13,069
Cash, cash equivalents and restricted cash at end of period	11,702	7,075
Supplemental Cash flow information:
Cash payments for interest	388	278
Cash payments for income taxes	34	20
Non-cash operating, investing and financing transactions:
Acquisition of capital expenditures in accounts payable and accrued expenses	183	1,365
Capitalized stock compensation in capital expenditures	$ 5	$ 10